David McDermott Selected Research

David McDermott Research Topics

Disease

26	Neoplasms (Cancer) 01/2022 - 07/2004
24	Renal Cell Carcinoma (Grawitz Tumor) 01/2022 - 08/2003
17	Melanoma (Melanoma, Malignant) 01/2019 - 02/2010
6	Kidney Neoplasms (Kidney Cancer) 01/2022 - 07/2004
3	Fatigue 01/2017 - 05/2010
2	Disease Progression 01/2021 - 05/2015
2	Nausea 01/2017 - 05/2010
2	Brain Neoplasms (Brain Tumor) 01/2014 - 05/2012
2	Exanthema (Rash) 05/2012 - 05/2007
1	COVID-19 01/2020
1	Proteinuria 01/2018
1	Hypertension (High Blood Pressure) 01/2018
1	Lymphoma (Lymphomas) 01/2017
1	Body Weight (Weight, Body) 05/2015
1	Inflammation (Inflammations) 07/2014
1	Dehydration (Water Stress) 05/2012
1	Neoplasm Metastasis (Metastasis) 05/2012
1	Colitis 05/2012
1	Hyperlipidemias (Hyperlipidemia) 05/2007
1	Hyperglycemia 05/2007
1	Edema (Dropsy) 05/2007
1	Asthenia 05/2007
1	Lung Neoplasms (Lung Cancer) 04/2005

Drug/Important Bio-Agent (IBA)

13	IpilimumabIBA 01/2022 - 05/2012
7	Bevacizumab (Avastin)FDA Link 12/2020 - 10/2007
7	Interleukin-2 (IL2)IBA 01/2019 - 08/2003
6	NivolumabIBA 01/2022 - 05/2015
6	CytokinesIBA 11/2018 - 08/2003
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018 - 09/2010
5	Sunitinib (Sutent)FDA Link 01/2022 - 05/2010
4	Immune Checkpoint InhibitorsIBA 01/2020 - 01/2014
4	temsirolimus FDA Link 08/2009 - 05/2007
3	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2021 - 12/2011
3	Biomarkers (Surrogate Marker)IBA 01/2019 - 01/2006
3	Monoclonal AntibodiesIBA 01/2018 - 05/2005
3	Angiogenesis InhibitorsIBA 01/2014 - 05/2010
3	Carbonic Anhydrase IXIBA 09/2010 - 05/2005
3	Interferon-alpha (Interferon Alfa)IBA 08/2009 - 05/2007
2	Tyrosine Kinase InhibitorsIBA 01/2021 - 01/2020
2	LigandsIBA 01/2018 - 12/2015
2	Pharmaceutical PreparationsIBA 01/2018 - 05/2012
2	Axitinib (AG 013736)IBA 01/2018 - 12/2011
2	AntigensIBA 02/2010 - 07/2004
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Everolimus FDA Link 01/2022
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2021
1	pazopanib FDA Link 01/2020
1	atezolizumabIBA 01/2019
1	navoximodIBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 01/2019
1	afliberceptIBA 11/2018
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2018
1	Alanine Transaminase (SGPT)IBA 01/2018
1	avelumabIBA 01/2018
1	Apoptosis Regulatory ProteinsIBA 01/2018
1	Immunoglobulin G (IgG)IBA 01/2018
1	Amylases FDA Link 01/2018
1	Lipase (Acid Lipase)FDA Link 01/2018
1	urelumabIBA 01/2017
1	E-SelectinIBA 10/2016
1	VemurafenibIBA 01/2014
1	Gemcitabine FDA Link 06/2012
1	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2012
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 05/2012
1	Sorafenib (BAY 43-9006)FDA Link 05/2010
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 04/2010
1	Paclitaxel (Taxol)FDA LinkGeneric 04/2010
1	Celecoxib (Celebrex)FDA Link 04/2010
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 03/2010
1	fludarabineIBA 03/2010
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 03/2010
1	tremelimumabIBA 02/2010
1	Phosphatidylinositols (Phosphatidylinositol)IBA 08/2009
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 10/2007
1	TensinsIBA 09/2007
1	TOR Serine-Threonine KinasesIBA 09/2007
1	InterferonsIBA 05/2007
1	ParaffinIBA 05/2005
1	Arginine (L-Arginine)FDA Link 04/2005
1	OrnithineIBA 04/2005
1	ArginaseIBA 04/2005
1	SuspensionsIBA 07/2004
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 07/2004
1	VaccinesIBA 07/2004

Therapy/Procedure

20	Therapeutics 01/2022 - 05/2005
2	Immunotherapy 10/2014 - 01/2014
1	Nephrectomy 01/2022
1	Palliative Care (Palliative Therapy) 09/2017
1	Radiotherapy 01/2014
1	Drug Therapy (Chemotherapy) 03/2010